These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 183194)

  • 21. Adenosine 3'5' cyclic monophosphate metabolism in patients with severe depressive illness.
    Jarrett DB; Newell B; Davies B; Coghlan JP
    Psychol Med; 1977 Feb; 7(1):93-101. PubMed ID: 193139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian rhythm in the urinary excretion of cyclic 3',5'-adenosine monophosphate in man.
    Sagel J; Colwell JA; Loadholt CB; Lizarralde G
    J Clin Endocrinol Metab; 1973 Oct; 37(4):570-3. PubMed ID: 4355092
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of electric convulsion therapy on urinary excretion of 3', 5' cyclic adenosine monophosphate.
    Hamadah K; Holmes H; Barker GB; Hartman GC; Perke DV
    Br Med J; 1972 Aug; 3(5824):439-41. PubMed ID: 4341644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical activity and plasma cyclic adenosine monophosphate levels in manic-depressive patients and healthy adults.
    Lykouras E; Garelis E; Varsou E; Stefanis CN
    Am J Psychiatry; 1979 Apr; 136(4B):540-2. PubMed ID: 218466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cyclic AMP on transformation and proliferation of leishmania cells.
    Walter RD; Buse E; Ebert F
    Tropenmed Parasitol; 1978 Dec; 29(4):439-42. PubMed ID: 217133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain.
    Volicer L; Hurter BP
    J Pharmacol Exp Ther; 1977 Feb; 200(2):298-305. PubMed ID: 190377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors determining urinary excretion of cyclic 3',5' AMP].
    Janiec W
    Pol Tyg Lek; 1972 Sep; 27(39):1534-6. PubMed ID: 4343652
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
    Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
    Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
    [No Abstract]   [Full Text] [Related]  

  • 29. [Concentration of cyclic adenosine-3',5'-monophosphate in the tissues and its excretion in the urine of rats during ontogenesis].
    Kostikova SN; Malykhina LS; Fedorov NA
    Ukr Biokhim Zh; 1976; 48(4):447-9. PubMed ID: 185768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lithium on cyclic 3',5'-adenosine monophosphate formation in brain slices and its influence on phosphodiesterase.
    Krulík R
    Arzneimittelforschung; 1977; 27(9):1660-3. PubMed ID: 200249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic adenosine monophosphate, adenyl cyclase and cyclic nucleotide phosphodiesterase in psoriatic epidermis, with a comment on urinary cAMP.
    Härkönen M; Hopsu-Havu VK; Raij K
    Acta Derm Venereol; 1974; 54(1):13-8. PubMed ID: 4135160
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of radioactive copper and of radioactive zinc for psychiatric diagnosis].
    Czerniak P; Zwas ST
    Ann Med Psychol (Paris); 1976 Apr; 134(4):566-76. PubMed ID: 952438
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) in asthmatic and normal children.
    König P; Carpenter M; White AA
    Eur J Respir Dis; 1980 Aug; 61(4):218-26. PubMed ID: 6258958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric services and mental illness in Iceland. Incidence study (1966-1967) with 6-7 year follow-up.
    Helgason L
    Acta Psychiatr Scand Suppl; 1977; (268):1-140. PubMed ID: 268138
    [No Abstract]   [Full Text] [Related]  

  • 35. Eye-tracking performance in psychiatric patients.
    Shagass C; Amadeo M; Overton DA
    Biol Psychiatry; 1974 Dec; 9(3):245-60. PubMed ID: 4441576
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
    Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
    J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary adenosine 3',5'-cyclic monophosphate: effects of electroconvulsive therapy.
    Moyes R; Moyes IC
    Br J Psychiatry; 1976 Aug; 129():173-7. PubMed ID: 183851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary excretion and cerebrospinal fluid concentration of cyclic adenosine-3',5'-monophosphate in various neurological diseases.
    Heikkinen ER; Myllylä VV; Vapaatalo H; Hokkanen E
    Eur Neurol; 1974; 11(5):270-80. PubMed ID: 4369423
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of electro-convulsive therapy on the urinary excretion of adenosine 3':5'-cyclic monophosphate.
    Hamadah K; Holmes H; Barker G; Hartman GC; Parke DV
    Biochem J; 1972 Nov; 130(1):15P. PubMed ID: 4347777
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary excretion of adenosine 3' :5'-cyclic monophosphate in depressive illness.
    Naylor GJ; Stansfield DA; Whyte SF; Hutchinson F
    Br J Psychiatry; 1974 Sep; 125(0):275-9. PubMed ID: 4370674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.